Stocks Health care UTMD
NASDAQ · Health careUtah Medical Products Inc (UTMD)
Utah Medical Products Inc brought in $36.1M of revenue over the twelve months to June 30, 2026, down 7.0% from a year earlier. Net income was $10.5M, a net margin of 29.0%. Operating cash flow minus capital spending left $14.3M of free cash flow in fiscal 2025. At June 30, 2026 it held $87.5M in cash against $195K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Key facts about Utah Medical Products Inc
- Net worth
- Utah Medical Products Inc has a market value (market cap) of $232M at the latest share price, and shareholders' equity of $122M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $38.5M (-5.8% year on year), with net income of $11.3M. Over the 12 months to June 30, 2026: revenue $36.1M, net income $10.5M.
- Cash flow
- In fiscal 2025 operations brought in $14.7M of cash; after $371K of capital spending, free cash flow was $14.3M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 12, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Utah Medical Products Inc's next report is expected around January 28, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Utah Medical Products Inc does
Utah Medical Products Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker UTMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $38.5M | $11.3M | $3.48 | $14.3M |
| 2024 | $40.9M | $13.9M | $3.96 | $14.6M |
| 2023 | $50.2M | $16.6M | $4.57 | $21.6M |
| 2022 | $52.3M | $16.5M | $4.52 | $20.3M |
| 2021 | $49.1M | $14.8M | $4.04 | $20.7M |
| 2020 | $42.2M | $10.8M | $2.94 | $19.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where UTMD ranks in Health care
Dividends
It paid out $4M in cash dividends, 35% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $4M | 35% |
| 2024 | n/a | $4.3M | 31% |
| 2023 | n/a | $4.3M | 26% |
| 2022 | n/a | $3.2M | 19% |
| 2021 | n/a | $11.5M | 78% |
| 2020 | n/a | $4.1M | 38% |
Latest SEC filings
What Utah Medical Products Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 3, 2026Other event 8-K
- October 29, 2026Form SC TO-I/A filing SC TO-I/A
- October 22, 2026
- October 5, 2026Form SC TO-I/A filing SC TO-I/A
- September 29, 2026Form SC TO-I/A filing SC TO-I/A
- September 25, 2026Form SC TO-C filing SC TO-C
- September 24, 2026Form SC TO-C filing SC TO-C
- September 24, 2026Form SC 13E3 filing SC 13E3
- September 17, 2026Form SC TO-C filing SC TO-C
- August 31, 2026
What is UTMD worth? A DCF from its reported cash flow
Insider trades
What the people running Utah Medical Products Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $66.8K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 29, 2026 | Cornwell Kevin LChairman, CEO, Director | Boughtindirect | 1,000 | $66.8K |
| June 29, 2026 | Richins Paul ODirector | Gave as a giftindirect | 150 | $11K |
| May 28, 2026 | Koopman BrianPrincipal Financial Officer | Gave as a gift | 50 | $3.3K |
Who owns UTMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Brandes Investment Partners, LP13G, passive with 1 related filers | 14.9% | August 14, 2026 |
| Dimensional Fund Advisors LP13G, passive | 6.1% | July 15, 2025 |
| Renaissance Technologies LLC13G, passive with 1 related filers | 5.52% | August 13, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 114 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Brandes Investment Partners, LP | 475,158 | +25,879 |
| BlackRock, Inc. | 203,690 | +16,041 |
| Dimensional Fund Advisors LP | 198,817 | +909 |
| Renaissance Technologies LLC | 175,814 | -8,300 |
| Vanguard Capital Management LLC | 134,535 | -4,025 |
| Geode Capital Management, LLC | 108,048 | -12,049 |
| Minerva Advisors LLC | 93,615 | 0 |
| Hotchkis & Wiley Capital Management LLC | 85,231 | -3,900 |
| Rice Hall James & Associates, LLC | 71,363 | +3,481 |
| Morgan Stanley | 69,671 | +20,870 |
| State Street Corp | 63,937 | -465 |
| Quantinno Capital Management LP | 43,074 | +13,233 |
| UBS Group AG | 34,369 | -2,547 |
| Bank of New York Mellon Corp | 34,263 | +2,181 |
| Northern Trust Corp | 30,104 | -188 |
| Huber Capital Management LLC | 29,009 | -6,906 |
| Cardinal Capital Management | 27,094 | +551 |
| Everett Harris & Co | 23,933 | -1,631 |
| O'Shaughnessy Asset Management, LLC | 21,683 | +396 |
| Segall Bryant & Hamill, LLC | 21,547 | 0 |
Insiders
3 insiders reported holding 211,019 shares in total, about $15.4M at the last price.
| Holder | Shares |
|---|---|
| Cornwell Kevin LChairman, CEO, Director | 189,472189,472 held indirectly |
| Richins Paul ODirector | 20,76520,765 held indirectly |
| Koopman BrianPrincipal Financial Officer | 782 |
Questions about UTMD
What does Utah Medical Products Inc do?
Utah Medical Products Inc is a company in the Health care sector, listed on NASDAQ as UTMD. Its shares trade on NASDAQ under the ticker UTMD.
What is Utah Medical Products Inc's net worth?
Utah Medical Products Inc has a market value (market cap) of $232M at the latest share price, and shareholders' equity of $122M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Utah Medical Products Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $10.5M on revenue of $36.1M, a net margin of 29.0%.
How much revenue does Utah Medical Products Inc make?
Over the twelve months to June 30, 2026 Utah Medical Products Inc reported revenue of $36.1M. That is 7.0% less than a year earlier.
When did Utah Medical Products Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from November 3, 2026.
When is Utah Medical Products Inc's next earnings report?
Utah Medical Products Inc's next report is expected around January 28, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare UTMD with
Follow UTMD
Get an email when Utah Medical Products Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Utah Medical Products Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.